DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Holgate ST, Chuchalin AG, Hébert J. , et al; Omalizumab 011 International Study Group.
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
Clin Exp Allergy 2004;
34 (04) 632-638
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.